Cargando…
Bullatacin triggers immunogenic cell death of colon cancer cells by activating endoplasmic reticulum chaperones
BACKGROUND: It is well accepted that the immune system efficiently contributes to positive outcomes of chemotherapeutic cancer treatment by activating immunogenic cell death (ICD). However, only a limited number of ICD-inducing compounds are well characterized at present; therefore, identification o...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194247/ https://www.ncbi.nlm.nih.gov/pubmed/34112202 http://dx.doi.org/10.1186/s12950-021-00289-1 |